Protective effect of prostaglandin EP4-receptor agonist on anti-glomerular basement membrane antibody-associated nephritis

Journal of Pharmacological Sciences

Volumn 102, Issue 2, 2006, Pages 182-188

  Nagamatsu, Tadashi ^a   Imai, Hirohito ^a   Yokoi, Michiyo ^a   Nishiyama, Tsutomu ^b   Hirasawa, Yasushi ^a   Nagao, Toshiyuki ^a   Suzuki, Yoshio ^a  

^a MEIJO UNIVERSITY   (Japan)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Agonist; EP4 receptor; Mouse; Nephritis; Prostaglandin E2

Indexed keywords

AE 1 329; CHOLESTEROL; CREATININE; CYCLIC AMP; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; GLOMERULONEPHRITIS; HORMONE SYNTHESIS; IMMUNOGLOBULIN DEPOSITION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINALYSIS;

EID: 33750608891     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0060401     Document Type: Article

References (32)

1. Sraer J, Foidart J, Chansel P, Mahiew P, Ardaillou R. Prostaglandin synthesis by rat isolated glomeruli and glomerular cultured cells. Int J Biochem. 1980;12:203-207.
2. Lianos EA, Andres GA, Dunn MJ. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics. J Clin Invest. 1983;72:1439-1448.
3. Stork JE, Dunn MJ. Hemodynamic roles of thromboxane A and prostaglandin E in glomerulonephritis. J Pharmacol Exp Ther. 1985;233:672-678.
4. Nagao T, Nagamatsu T, Suzuki Y. Effect of lipo-prostaglandin E1 on crescentic-type anti-glomerular basement membrane nephritis. in rats. Eur J Pharmacol. 1998;384:37-44.
5. 2 subtype. Prostaglandins. 1997;54:713-725.
6. Sugimoto Y, Namba T, Shigemoto R, Negishi M, Ichikawa A, Narumiya S. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am J Physiol. 1994;266:F823-F828.
7. 2 clearance of aggregated protein via protein kinase A in glomerulus. Jpn J Pharmacol. 2001;85:139-145.
8. 1, TEI-5178 and TEI-6122, on crescentic-type anti-GBM nephritis in rats. Jpn J Pharmacol. 1989;51:521-530.
9. Nagamatsu T, Ishikami H, Nishiyama T, Suzuki Y. Induction of cyclooxygenase-2 expression in glomeruli by aggregated protein. Jpn J Pharmacol. 2002;89:373-379.
10. Nagamatsu T, Nishiyama T, Goto I, Nagao T, Suzuki Y. Adenosine 3′,5′ cyclic monophosphate attenuates the basement membrane antibody-associated nephritis. Br J Pharmacol. 2003;140:1245-1251.
11. 1 on disposal of heat-aggregated bovine serum albumin in the glomerulus. Jpn J Pharmacol. 1988;46:397-402.
12. Nagao T, Koseki J, Suzuki Y, Nagamatsu T. Thromboxane A2 cause retarded clearance of aggregated protein in glomeruli of nephritic mice. Eur J Pharmacol. 2001;413:271-279.
13. Assmann KJ, van Son JP, Koene RA. Improved method for the isolation of mouse glomeruli. J Am Soc Nephol. 1991;2:944-946.
14. Mosquera JA. Increase production of fibronectin by glomerular cultures from rats with nephrotoxic nephritis. Macrophages induce fibronectin productin in cultured mesangial cells. Lab Invest. 1993;68:406-412.
15. Watabe A, Sugimoto Y, Honda A, Irie A, Namba T, Negishi M, et al. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem. 1993;268:20175-20178.
16. Katsuyama M, Nishigaki N, Sugimoto Y, Morimoto K, Negishi M, Narumiya S, et al. The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis. FEBS Lett. 1995;372:151-156.
17. Honda A, Sugimoto Y, Namba T, Watabe A, Irie A, Negishi M, et al. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem. 1993;268:7759-7762.
18. Arakawa T, Laneuville O, Miller CA, Lakkides KM, WingerdI BA, Dewitt DL, et al. Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells. Structure and expression of the murine prostaglandin EP4 receptor gene. J Biol Chem. 1996;271:29569-29575.
19. Nagamatsu T, Nagao T, Hayashi K, Suzuki Y. Antiproteinuric effect of KD3-671, an angiotensin II type 1 receptor antagonist, in rats with accelerated passive Heymann nephritis. Jpn J Pharmacol. 2002;88:213-216.
20. Chirkov YY, Chirkova LP, Sage RE, Horowitz JD. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1. J Cardiovasc Pharmacol. 1995;25:961-966.
21. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, et al. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 1993;366:307-308.
22. Hubbard NE, Lee S, Limd D, Erickson KL. Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation. Prostaglandins Leukot Essent Fatty Acids. 2001;65:287-294.
23. Pearse DD, Pereira FC, Marcillo AE, Baters ML, Berrocal YA, FilbinIL MT, et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med. 2004;10:610-616.
24. Kunikata T, Tanaka A, Miyazawa T, Kato S, Takeuhi K. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci. 2002;47:894-904.
25. Yoshida K, Oida H, Kobayashi T, Maruyama T, Tanaka M, Katayama T, et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci U S A. 2002;99:4580-4585.
26. Xiao CY, Yuhki K, Hara A, Fujino T, Kuriyama S, Yamada T, et al. Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation. 2004;109:2462-2468.
27. 2 that regulate cellular immune responses in the mouse. J Clin Invest. 2001;108:1229-1235.
28. Fennekohl A, Sugimoto Y, Segi E, Maruyama T, Ichikawa A, Puschel GP. Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the inhibition by PGE2 of the LPS-induced TNFalpha-formation in Kupffer cells from EP2- or EP4-receptor-deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells. J Hepatol. 2002;36:328-334.
29. Timoshanko JR, Sedgwick JD, Holdworth SR, Tipping PG. Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol. 2003;14:1785-1793.
30. Hattori T, Nagamatsu T, Ito M, Suzuki Y. Contribution of ED-1-and CD-8-positive cells to the development of crescentic-type anti-GBM nephritis in rats. Nippon Jinzo Gakkai Shi. 1994;36:1228-1239.
31. Hui AY, Dannenberg AJ, Sung JJ, Subbaramaiah K, Du B, Olinga P, et al. Prostaqglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells. J Hepatol. 2004;41:251-258.
32. 2 interferes a disposal process of aggregated protein in glomeruli. Jpn J Pharmacol. 1997;75:381-390.